Licensing, Acquisition, and Other Arrangements - Acquisition of Luminera (Details) - USD ($) $ in Millions |
1 Months Ended | |||
|---|---|---|---|---|
Oct. 31, 2020 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Business Acquisition | ||||
| Goodwill | $ 32,156 | $ 32,379 | $ 33,124 | |
| Luminera | ||||
| Business Acquisition | ||||
| Total consideration | $ 186 | |||
| Upfront cash payment | 122 | |||
| Contingent consideration | 64 | |||
| Maximum future payments upon achievement of certain milestones | 90 | |||
| Intangible assets - Developed product rights | 127 | |||
| Intangible assets - In-process research and development | 33 | |||
| Goodwill | $ 12 |
| X | ||||||||||
- Definition Represents the maximum additional payment for research and early development of collaboration projects. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|